Admission Date:  [**2119-2-10**]              Discharge Date:   [**2119-2-23**]  Date of Birth:  [**2039-4-25**]             Sex:   M  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 2932**] Chief Complaint: aspiration pna  Major Surgical or Invasive Procedure: None   History of Present Illness: 79 y/o male with multi-infarct dementia, recent hemmorrhagic cerebellar stroke who presents from home after found to be in respiratory distress.
Patient was placed on NRB and O2Sat increased to 99%.
He was given a dose of ceftriaxone and flagyl and azithromycin.
Laboratory studies on admission: [**2119-2-10**] WBC-23.2 HGB-13.9 HCT-40.7 MCV-86 RDW-14.5 PLT COUNT-636 PT-13.0 PTT-27.4 INR(PT)-1.1 U/A: BLOOD-LG NITRITE-POS PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-4 PH-5.0 LEUK-TR RBC-0-2 WBC-0-2 BACTERIA-MANY YEAST-NONE EPI-0 Stox: ASA-NEG ETHANOL-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG LACTATE-2.1 [**2119-2-11**] [**2119-2-11**] 03:21AM BLOOD Glucose-146* UreaN-23* Creat-1.1 Na-130* K-7.6* Cl-97 HCO3-23  Laboratory studies on discharge: WBC-12.1 Hgb-14.0 Hct-44.0 MCV-91 RDW-13.7 Plt Ct-835* Glucose-136* UreaN-27* Creat-1.0 Na-135 K-4.9 Cl-97 HCO3-27 AnGap-16  Radiology [**2119-2-10**] CXR: Patchy consolidation in the left lower lung, concerning for pneumonia.
He was evaluated by the speech and swallow evaluation team, who recommended pureed solids and thin liquids, along with supervised feedings.
He will follow-up with his outpatient neurologist within 2 weeks for further dose adjustment.
4) Hypertension: The patient was treated with lisinopril and metoprolol.
Hydrochlorothiazide was discontinued given possible gout (see below).
An arthrocentesis was attempted without success due to poor positioning in the setting of left lower extremity contracture.
He was treated empirically with a 7 day course of low dose prednisone (prior uric acid levels had been elevated) with improvement in symptoms.
They felt that this was most likely a reactive phenomenon in the setting of acute illness, and recommended serial follow-up as an outpatient.
If it persists after treatment of aspiration pneumonia, further work-up, such as bone marrow biopsy, may be considered.
The patient was continued on low dose aspirin prophylactically.
DNR/DNI  Medications on Admission: 1.
Docusate 100 mg po bid prn constipation 2.
Folic acid 1 mp po daily 3.
Lisinopril 10 mg po daily 4.
HCTZ 25 mg po daily 5.
ASA 81 mg po daily Stopped Sinemet after d/c from [**Hospital1 2177**]  Discharge Medications: 1.
Lisinopril 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily).
Carbidopa-Levodopa 25-100 mg Tablet Sig: One (1) Tablet PO TID (3 times a day).
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed for constipation.
Cyanocobalamin 500 mcg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Metoprolol Tartrate 25 mg Tablet Sig: 0.5 Tablet PO BID (2 times a day).
Ciprofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours) for 2 days.
Metronidazole 500 mg Tablet Sig: One (1) Tablet PO TID (3 times a day) for 2 days.
Acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q4-6H (every 4 to 6 hours) as needed for pain.
Discharge Disposition: Home  Discharge Diagnosis: Primary: aspiration pneumonia Secondary: aspiration pneumonia, thrombocytosis, subacute cerebellar CVA, hypertension, gout   Discharge Condition: Stable   Discharge Instructions: Please follow-up as indicated below.
Please take all medications as prescribed.
